-
1
المؤلفون: Hirva Mamdani (9502091), Bryan Schneider (7136765), Susan M. Perkins (9744956), Heather N. Burney (11447728), Pashtoon Murtaza Kasi (7409255), Laith I. Abushahin (11447731), Thomas Birdas (4333678), Kenneth Kesler (4333681), Tracy M. Watkins (11447734), Sunil S. Badve (5811344), Milan Radovich (172973), Shadia I. Jalal (1505551)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, durvalumab, immunotherapy, esophageal adenocarcinoma, GEJ adenocarcinoma, locally advanced esophagogastric adenocarcinoma, relapse free survival, CIBERSORT, immune cell deconvolution
-
2
المؤلفون: Hirva Mamdani, Bryan Schneider, Susan M. Perkins, Heather N. Burney, Pashtoon Murtaza Kasi, Laith I. Abushahin, Thomas Birdas, Kenneth Kesler, Tracy M. Watkins, Sunil S. Badve, Milan Radovich, Shadia I. Jalal
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, durvalumab, immunotherapy, esophageal adenocarcinoma, GEJ adenocarcinoma, locally advanced esophagogastric adenocarcinoma, relapse free survival, CIBERSORT, immune cell deconvolution
الإتاحة: https://doi.org/10.3389/fonc.2021.736620.s001Test
https://figshare.com/articles/dataset/DataSheet_1_A_Phase_II_Trial_of_Adjuvant_Durvalumab_Following_Trimodality_Therapy_for_Locally_Advanced_Esophageal_and_Gastroesophageal_Junction_Adenocarcinoma_A_Big_Ten_Cancer_Research_Consortium_Study_docx/16634374Test